Jazz Pharma Ruling Clears US Roadblock for Rival Narcolepsy Drug ...Middle East

A US appeals court ordered Jazz Pharmaceuticals on Friday to de-list a patent related to its blockbuster narcolepsy drug Xyrem from the FDA's register of approved medications, in a win for rival drugmaker Avadel CNS Pharmaceuticals. Reuters Health Information

Hence then, the article about jazz pharma ruling clears us roadblock for rival narcolepsy drug was published today ( Monday 27/02/2023 - 09:48 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jazz Pharma Ruling Clears US Roadblock for Rival Narcolepsy Drug )

Also on site :

• Natural gas line rupture stops traffic on 5 Freeway in Castaic
• 30–35 terrorists on radar: Army steps up counterterror ops in J&K; intense vigil amid 'Chillai Kalan'
• No. 20 Virginia notches first 11-win season by beating 25th-ranked Missouri in the Gator Bowl